Early rebleeding and death at 6 weeks in alcoholic cirrhotic patients with acute variceal bleeding treated with emergency endoscopic injection sclerotherapy

South African Journal of Surgery

Volumn 47, Issue 3, 2009, Pages 72-79

  Krige, J E J ^a   Shaw, J M ^a   Bornman, P C ^a   Kotze, U K ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

SCLEROSING AGENT;

ACUTE DISEASE; ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; EMERGENCY; ESOPHAGUS VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS; HUMAN; INJECTION; MALE; MIDDLE AGED; MORTALITY; RECURRENT DISEASE; SCLEROTHERAPY;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; EMERGENCIES; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS, ENDOSCOPIC; HUMANS; INJECTIONS; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MIDDLE AGED; RECURRENCE; SCLEROSING SOLUTIONS; SCLEROTHERAPY;

EID: 70249123440     PISSN: 00382361     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Bosetti C, Levi F, Lucchini F, et al. Worldwide mortality from cirrhosis: An update to 2002. J Hepatol 2007; 46: 827-839.
2. Leon DA, McCambridge J. Liver cirrhosis mortality rates in Britain from 1950 to 2002: An analysis of routine data. Lancet 2006; 367: 52-56.
3. Roberts SE, Goldacre MJ.Yeates D. Trends in mortality after hospital admission for liver cirrhosis in an English population from 1968 to 1999. Gut 2005; 54:1615-1621.
4. De Franchis R. Emerging strategies in the management of upper gastrointestinal bleeding. Digestion 1999; 60: Suppl 3,17-24.
5. Del Olmo JA, Peña A, Serra MA,Wassel AH, Benages A, Rodrigo JM. Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis. J Hepatol 2000; 32:19-24.
6. Sharara Al, Rockey DC. Gastroesophageal variceal hemorrhage. N Engl J Med 2001; 345:669-681.
7. Krige JEJ, Shaw JM, Bornman PC. The evolving role of endoscopic treatment for bleeding esophageal varices. Wbrld J Surg 2005; 29: 966-973.
8. Triantos CK, Goulis J, Patch D, et al. An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye. Endoscopy 2006; 38:797-807.
9. Baradarian R, Ramdhaney S, Chapalamadugu R, et al. Early intensive resuscitation of patients with upper gastrointestinal bleeding decreases mortality. Am J Gastroenterol 2004; 99:619-622. (Pubitemid 38607962)
10. Berry PA.Wendon JA.The management of severe alcoholic liver disease and variceal bleeding in the intensive care unit. Curr Opin Crit Care 2006; 12: 171-177.
11. Chalasani N, Kahi C, Francois F, et al. Improved patient survival after acute variceal bleeding: A multicenter, cohort study. Am J Gastroenterol 2003; 98: 653-659.
12. Stokkeland K, Brandt L, Ekbom A, Hultcrantz R. Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969-2002. Hepatology 2006; 43: 500-505.
13. Le Moine O, Adler M, Bourgeois N, et al. Factors related to early mortality in cirrhotic patients bleeding from varices and treated by urgent sclerotherapy. Gut 1992; 33: 1381-1385.
14. Longacre AV, Garcia-Tsao G. A commonsense approach to esophageal varices. Clin Liver Dis 2006; 10:613-625.
15. Mihas AA, Sanyal AJ. Recurrent variceal bleeding despite endoscopic and medical therapy. Gastroenterology 2004; 127: 621-629.
16. Azoulay D, Castaing D, Majno P, et aL Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 2001; 35: 590-597.
17. Thomsen BL, Serensen TI. Analysis of the treatment effect on recurrent bleeding and death in patients with cirrhosis and esophageal varices: multistage competing-risks model compared to conventional methods. The Copenhagen Esophageal Varices Sclerotherapy Project. J Hepatol 1998; 28: 107-114.
18. De Franchis R, Pascal JP, Ancona E, et al. Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol 1992;15:256-261.
19. De Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43:167-176.
20. Jalan R, Hayes PC. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut 2000; 46: Suppl 3-4, III1-III15.
21. Pugh S, Lewis S, Smith PM. Bleeding oesophageal varices in alcoholic cirrhosis: long-term follow-up of endoscopic sclerotherapy. Q J Med 1993; 86: 241-245.
22. Hartigan PM, Gebhard RL, Gregory PB. Sclerotherapy for actively bleeding esophageal varices in male alcoholics with cirrhosis. Veterans Affairs Cooperative Variceal Sclerotherapy Group. Gaarointest Endosc 1997; 46:1-7.
23. Gluud C, Henriksen JH, Nielsen G. Prognostic indicators in alcoholic cirrhotic men. Hepatology 1988; 8:222-227.
24. Vorobioff J, Groszmann RJ, Picabea E, et al. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: A 10-year prospective study. Gastroenterology 1996; 111: 701-709.
25. Grace ND, Groszmann RJ, Garcia-Tsao G, et al. Portal hypertension and variceal bleeding: An AASLD single topic symposium. Hepatology 1998; 28: 868-880.
26. Krige JEJ, Terblanche J. Injection sclerotherapy of oesophageal varices. In: Carter D, Russell RCG, Pitt H, Bismuth H, eds. Rob and Smith's Operative Surgery. Surgery of the Liver, Pancreas and Bile Ducts. 5th ed. London: Chapman & Hall Medical, 1996:163-172.
27. Krige JEJ, Bornman PC. Endoscopic therapy in the management of esophageal varices: injection sclerotherapy and variceal ligation. In: Blumgart L, ed. Surgery of the Liver, Biliary Tract and Pancreas. 4th ed. Philadelphia: Saunders Elsevier, 2007:1579-1593.
28. Krige JEJ, Bornman PC. Endoscopic therapy in the management of esophageal varices: injection sclerotherapy and variceal ligation. In: Fischer JE, ed. Mastery of Surgery. 5th ed. Philadelphia: Lippincott Williams & kins, 2006:1367-1378.
29. Graffeo M, Bufibli F, T jnzani G, et al. Survival after endoscopic sclerotherapy for esophageal varices in cirrhotics. Am J Gastroenterol 1994; 89: 1815-1822.
30. Abraldes JG, Bosch J. The treatment of acute variceal bleeding. J Clin Gastroenterol 2007; 41; S312-S317.
31. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey WD. Practice Guidelines Committee of American Association for Study of Liver Diseases; Practice Parameters Committee of American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol 2007; 102:2086-2102.
32. De Franchis R, Dell'Era A. Non-invasive diagnosis of cirrhosis and the natural history of its complications. Best Pract Res Clin Gastroenterol 2007; 21: 3-18.
33. D'Amico G, De Franchis R; Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003; 38: 599-612.
34. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80:800-809.
35. Garrett KO, Reilly JJ Jr, Schade RR, van Thiel DH. Sclerotherapy of esophageal varices: long-term results and determinants of survival. Surgery 1988; 104:813-818.
36. Thomopoulos K, Theocharis G, Mimidis K, Lampropoulou-Karatza Ch, Alexandridis E, Nikolopoulou V. Improved survival of patients presenting with acute variceal bleeding. Prognostic indicators of short- and long-term mortality. Dig Liver Dis 2006; 38: 899-904.
37. Wiesner RH, McDiarmid SV, Kamath PS, et al. MELD and PELD: Application of survival models to liver allocation. LiverTranspl 2001; 7: 567-580.
38. Boix J, Lorenzo-Zúñiga V, Moreno de Vega V, Domenech E, Gassull MA. Sclerotherapy and esophageal variceal bleeding: Time to forget it, or not? Endoscopy 2007; 39:478.
39. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. J Hepatol 2006;44:217-231.
40. Angermayr B, Cejna M, Karnel F, et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 2003; 52: 879-885. (Pubitemid 36613497)
41. Garcia-Tsao G, Bosch J, Groszmann RJ. Portal hypertension and variceal bleeding - unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference. Hepatology 2008; 47:1764-1772.
42. Atkinson RJ, Hurlstone DP. Usefulness of prognostic indices in upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol 2008; 22: 233-242.
43. Sanders DS, Carter MJ, Goodchap RJ, Cross SS, Gleeson DC, Lobo AJ. Prospective validation of the Roc kail risk scoring system for upper GI hemorrhage in subgroups of patients with varices and peptic ulcers. Am J Gastroenterol 2002; 97:630-635.
44. Cholongitas E, Papatheodoridis GV, Vangeli M, Terreni N, Patch D, Burroughs AK. Systematic review: The model for end-stage liver disease - should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther 2005; 22:1079-1089.
45. Krige JEJ, Beningfield SJ, Shaw J. Management of bleeding oesophageal varices. In: Johnson C, Taylor I, eds. Recent Advances in Surgery. 30th ed. London: Royal Society of Medicine, 2007:105-125.
46. Krige JE, Bornman PC, Shaw JM, Apostolou C. Complications of endoscopic variceal therapy. S Afr J Surg 2005; 43: 176-194.
47. Krige JEJ.Terblanche J, Bornman PC. Complications of endoscopic variceal sclerotherapy. In: Sivak MV, ed. Gastroenterologic Endoscopy. 2nd ed. New Yorfc W.B. Saunders,1999:413-428.
48. Tait IS, Krige JE, Terblanche J. Endoscopic band ligation of oesophageal varices. Br J Surg 1999; 86: 437-446.
49. Sorbi D, Gostout CJ, Peura D, et al. An assessment of the management of acute bleeding varices: A multicenter prospective member-based study. Am J. Gastroenterol 2003; 98: 2424-2434.
50. Madonia S, D'Amico G. Traina M, et al. Prognostic indicators of successful endoscopic sclerotherapy for prevention of rebleeding from oesophageal varices in cirrhosis: A long-term cohort study. Dig Liver Dis 2000; 32: 782-791.
51. De Franchis R, Banares R, Silvain C. Emergency endoscopy strategies for improved outcomes. Scand J Gastroenterol Suppl 1998; 226: 25-36.
52. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Lévy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004; 40: 652-659.
53. Thabut D, Bernard-Chabert B. Management of acute bleeding from portal hypertension. Best Pract Res Clin Gastroenterol 2007; 21:19-29. (Pubitemid 46076005)
54. Vangeli M, Patch D, Burroughs AK. Salvage tips for uncontrolled variceal bleeding. J Hepatol 2002; 37: 703-704.
55. Zehetner J, Shamiyeh A, Wayand W, Hubmann R. Results of a new method to stop acute bleeding from esophageal varices: implantation of a self-expanding stent. Surg Endosc 2008; 22:2149-2152.
56. Lo GH, Chen WC, Lin CK, et al. Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding. Hepatology 2008; 48: 580-587.
57. Bureau C, Garcia-Pagan JC, Otal P, et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 2004; 126:469-475.